15
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Effect of Benzylpenicillin in Mice Infected with Endotoxin-liberating or Non-liberating Variant Strains of Neisseria meningitidis

&
Pages 257-266 | Published online: 08 Jul 2009
 

Abstract

The effect of benzylpenicillin treatment was studied in mice infected intraperitoneally (i.p.) with endotoxin-liberating (E+) and non-liberating (E-) meningococci derived from the same original serogroup B strain. The E+ meningococci were significantly more virulent to mice than the E-variants in untreated animals (p < 0.001). Large doses of benzylpenicillin given intravenously (i.v.) immediately after i.p. inoculation of E+ or E-meningococci resulted in complete, or almost complete survival. When treatment started later the number of surviving E-infected animals increased in all treatment regimens. By contrast, E+ infected animals had one or more treatment groups in all regimens that did not respond to benzylpenicillin at all. Benzylpenicillin treatment was given over a period of time as intermittent, regular i.v. doses, or as a depot preparation subcutaneously (s.c.). The mortality observed in E+ infected mice after benzylpenicillin i.v. was 75%, after benzylpenicillin procaine s.c. 82.5%, while animals receiving only saline i.v. had a mortality of 67.5%. The corresponding mortalities for E-infected animals were 15 % (p = 0.0014), 42.5%, and 42.5%, respectively.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.